Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab. Radiol Oncol. 2026;60(1):40-48. Accessed October 22, 2026. https://radioloncol.com/index.php/ro/article/view/4783